Hallandale Pharmacy
503A Outsourcing Facility — FDA safety data from public records
On This Page
Florida-based compounder operating across 503B outsourcing and 503A pharmacy functions, with a significant presence in sterile medication fulfillment.
Website: hallandalepharmacy.com
Data last verified: 2026-04-25
Company Snapshot
Entity Type
503A Outsourcing Facility
FDA Registration
active
Warning Letters
0
Recalls
0
States Licensed
Not listed
Compounding Status
both
What This Company Profile Actually Tells You
Hallandale Pharmacy is categorized here as a 503B outsourcing facility or closely related sterile compounding operation. That matters because 503B facilities occupy a different regulatory lane than telehealth brands: they are physical drug establishments with FDA-facing registration obligations and manufacturing-style oversight expectations.
Hallandale Pharmacy's exact geographic footprint is not summarized on this page, so readers should confirm state availability before assuming access in their market. Readers evaluating a 503B facility should care about sterility controls, batch processes, inspection history, recalls, and whether the facility role being marketed to the public matches the legal operating status reflected in FDA records.
From a search and trust perspective, these pages need to answer a more technical question than a typical company review. Users are not just deciding whether they like the brand. They are trying to understand whether the facility is properly registered, how it is classified, and what public safety signals exist around its operations.
Hallandale Pharmacy Background
Market Position
Hallandale Pharmacy is frequently discussed as an underlying fulfillment partner in the telehealth GLP-1 ecosystem rather than as a consumer brand discovered first by patients. That makes its role especially important in safety and sourcing conversations.
Business Model
Unlike a telehealth platform, Hallandale's significance comes from operating as a physical compounding facility. Readers are usually evaluating it because another company uses the pharmacy in the background, not because the patient relationship starts with Hallandale itself.
Pharmacy And Supply Notes
For consumers, Hallandale is the kind of name that often appears after they ask a telehealth seller where medication is actually coming from. When that happens, registration status, facility classification, and any public enforcement history become much more important than brand marketing.
Consumer Risk Notes
The key risk question is not whether Hallandale looks reputable on a landing page, but whether the exact facility role, compounding framework, and lot-level quality practices are clear enough for patients and prescribers to verify.
Key Facts
Hallandale matters because it may sit behind the scenes of telehealth GLP-1 fulfillment rather than in front of the patient.
Its active FDA registration status is a useful facility-verification signal, but it is not the same as drug approval.
Patients should still ask any prescribing platform to identify the exact pharmacy and explain how quality documentation is handled.
Risk Summary
No FDA warning letters are currently shown in this profile.
No recall events are currently shown in the FDA enforcement data surfaced here.
FDA registration status is shown as active.
Compounding status is listed as both.
Regulatory And Compliance Analysis
Registration Context
Hallandale Pharmacy shows an active FDA registration record in the establishment database. That is a useful signal for facility verification, but it should still be read as registration data rather than a product approval or quality guarantee.
Warning Letter Readout
We did not find FDA warning letters for Hallandale Pharmacy in this profile. That is better than the alternative, but it is not a blanket endorsement. A clean warning-letter record only tells you that this page is not currently surfacing a published FDA warning letter tied to the entity.
Recall Readout
No recall events are shown for Hallandale Pharmacy here. For consumers, that lowers one category of concern, but it still does not replace verification of sourcing, labeling, temperature handling, and pharmacy quality controls.
Adverse Event Context
This profile does not currently show a meaningful adverse-event dataset for Hallandale Pharmacy. In practice, that usually means readers should lean more heavily on registration, recalls, warning letters, and pharmacy-partner transparency when evaluating risk.
FDA Registration
- Status
- FDA Registered
- FEI Number
- 3005947076
- Facility Type
- 503B Outsourcing Facility
- Last Verified
- 2026-04-10
FDA Warning Letters (0)
No FDA warning letters are currently shown for Hallandale Pharmacy in this profile. That is helpful context, but users should still verify current marketing claims, pharmacy sourcing, and how the company describes compounded medications.
Recall History (0)
No recalls are currently displayed for Hallandale Pharmacy in the openFDA enforcement data surfaced on this page. That lowers one obvious risk signal, but it should not be treated as proof that all products, batches, or fulfillment practices are problem-free.
Source: openFDA Drug Enforcement API
Adverse Event Reports
This profile does not currently show a meaningful adverse-event summary for Hallandale Pharmacy. When that dataset is absent, readers should lean more on the documented public record around registration, recalls, warning letters, and pharmacy-partner transparency.
Source: FDA Adverse Event Reporting System (FAERS). Adverse event reports do not establish causation.
Questions Patients Should Ask Before Using Hallandale Pharmacy
Can Hallandale Pharmacy confirm the exact facility name, operating status, and whether the prescription will be filled under a 503A or 503B framework?
What does Hallandale Pharmacy tell patients about compounded versus FDA-approved products, and does that language avoid implying equivalence or approval where it does not exist?
How does Hallandale Pharmacy handle dose escalations, refill delays, refunds, cancellations, and temperature-sensitive shipping problems?
If a patient has a side effect or receives a product-quality concern, what is the human escalation path and how quickly does Hallandale Pharmacy respond?
Can Hallandale Pharmacy provide lot-level documentation, pharmacy details, and a clear explanation of what safety checks happen before medication is dispensed?
Similar Companies
These related profiles are useful for searchers comparing Hallandale Pharmacy against adjacent providers or pharmacies. Reading similar pages side by side usually reveals whether a concern is unique to one company or common across this category.
How To Use This Profile
This profile organizes public-source safety signals for Hallandale Pharmacy, including FDA registration status, warning letters, recalls, and any adverse event summary data available in the dataset.
A company can appear relatively clean here and still deserve more diligence, because absence of a warning letter or recall is not the same as proof of quality.
For 503a outsourcing facility pages especially, readers should distinguish between the consumer-facing brand and the pharmacy or facility that actually handles medication production or dispensing.
Looking for a Verified GLP-1 Provider?
FormBlends partners with licensed 503A compounding pharmacies. Every compound is third-party tested with certificates of analysis.
Learn MoreDisclaimer: This page aggregates publicly available data from the FDA, state pharmacy boards, and other government sources. It is provided for informational purposes only and does not constitute medical or legal advice. FDA registration does not imply FDA approval or endorsement. The absence of warning letters or recalls does not guarantee safety or quality. Always consult your healthcare provider before making decisions about medications. Data may not reflect the most current status. Last updated: 2026-04-25.
Safety Guides
503A vs 503B pharmacies
Understanding the FDA oversight difference.
How to read a Certificate of Analysis
What every CoA should include and red flags to watch for.
What FDA registration actually means
Registration vs approval: the distinction most people miss.
Choosing a compounding pharmacy
What to verify before you fill your first prescription.
GLP-1 Safety Alerts
Get notified when the FDA issues warning letters, recalls, or regulatory updates affecting GLP-1 medications and compounding pharmacies.
Free. No spam. Unsubscribe anytime.
Frequently Asked Questions
Is Hallandale Pharmacy FDA registered?
Hallandale Pharmacy is currently registered with the FDA. Registration status was last verified on 2026-04-10. Note that FDA registration does not imply FDA approval or endorsement.
Has Hallandale Pharmacy received any FDA warning letters?
We have not found any FDA warning letters issued to Hallandale Pharmacy in our records. This page is updated regularly as new FDA data becomes available.
Does Hallandale Pharmacy have any recalls?
We have not found any recalls associated with Hallandale Pharmacy in the openFDA enforcement database.
Is Hallandale Pharmacy a telehealth company or a pharmacy?
Hallandale Pharmacy is categorized in this profile as a 503a outsourcing facility. That distinction matters because a telehealth brand, a 503A pharmacy, and a 503B outsourcing facility operate under different regulatory expectations.
Does a clean profile mean Hallandale Pharmacy is definitely safe?
No. A clean profile means we are not currently surfacing certain FDA signals like warning letters or recalls for Hallandale Pharmacy. It does not guarantee product quality, customer-service quality, or future regulatory compliance.
What should patients verify before using Hallandale Pharmacy?
Patients should verify who is prescribing, which pharmacy or outsourcing facility is actually fulfilling the medication, what the company says about compounded versus FDA-approved products, and how billing, cancellations, and side-effect escalation are handled.